NEU 1.03% $19.30 neuren pharmaceuticals limited

bell potter research report - 12c target, page-3

  1. 10,928 Posts.
    lightbulb Created with Sketch. 1251
    "We value Neuren on a probability-weighted DCF valuation at 12 cents base case and 21 cents optimistic`case."
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.